Biopharma Faces a Tsunami of Layoffs in 2025, Yet Silver Linings Emerge with AI-Driven Consolidations
As the biopharma industry witnesses an unprecedented wave of layoffs in 2025, marked by a 31% increase, strategic consolidation offers a glimmer of hope. While tens of thousands of employees face workforce reductions, the industry shifts focus towards AI and specialized skill sets, highlighting new opportunities amid the turmoil.
Aug 26